Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery

Cancer Epidemiology Biomarkers & Prevention
Dec 2008
Citations:197
Influential Citations:9
Interventional (Human) Studies
86
S2 IconPDF Icon

Enhanced Details

Methods
Multisite randomized presurgical 2x2 factorial trial (NCT00049309) enrolling 161 men with biopsy-proven prostate cancer scheduled for prostatectomy within 21 days; men aged 36-73 years; randomization stratified by race (Black vs non-Black) and biopsy Gleason sum (<7 vs ≥7).
Intervention
Ground flaxseed, 30 g/day (30 g daily), started with 10 g/day for days 1-3, 20 g/day for days 4-6, then 30 g/day thereafter, taken daily until prostatectomy (average 30 days on protocol).
Results
Ki-67 proliferation index in tumor tissue decreased with flaxseed: Control 3.23% (2.42-3.92), Flaxseed 1.66% (1.13-2.64), Low-fat 2.56% (2.00-3.69), Flaxseed+Low-fat 1.50% (1.05-2.65); flaxseed effect P=0.0013; low-fat effect P=0.661. No arm differences in apoptosis, Gleason sum, PSA, testosterone, or most serologic biomarkers; adherence to flaxseed was high and side effects were minimal. Conclusion: Flaxseed supplementation is safe and associated with biological changes that may be protective against prostate cancer by reducing tumor proliferation in the presurgical period; results support further larger trials to confirm effects and explore dose–response and interactions with fat restriction.
Limitations
Small sample size; short intervention duration; presurgical design; not powered to detect flaxseed × low-fat interactions; limited generalizability to long-term clinical outcomes.

Abstract

Background: Prostate cancer affects one of six men during their lifetime. Dietary factors are postulated to influence the development and progression of prostate cancer. Low-fat diets and flaxseed supplementation may offer potentially protective stra...